Success StoriesGSK acquires Nuvalent for $10.6 billion, expanding oncology pipelineGSK acquires Nuvalent for $10.6 billion, expanding its oncology pipeline and signaling a fierce race among pharma giants…Sarah Chen·June 9, 2026, 10:02 AM